iSpecimen (ISPC) Competitors $3.00 +0.04 (+1.35%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends ISPC vs. QMMM, INTJ, LIFW, RVYL, ESGL, DRCT, APDN, SRAX, CAUD, and ATIFShould you be buying iSpecimen stock or one of its competitors? The main competitors of iSpecimen include QMMM (QMMM), Intelligent Group (INTJ), MSP Recovery (LIFW), Ryvyl (RVYL), ESGL (ESGL), Direct Digital (DRCT), Applied DNA Sciences (APDN), SRAX (SRAX), Collective Audience (CAUD), and ATIF (ATIF). These companies are all part of the "business services" industry. iSpecimen vs. QMMM Intelligent Group MSP Recovery Ryvyl ESGL Direct Digital Applied DNA Sciences SRAX Collective Audience ATIF QMMM (NASDAQ:QMMM) and iSpecimen (NASDAQ:ISPC) are both small-cap business services companies, but which is the better business? We will contrast the two businesses based on the strength of their community ranking, valuation, dividends, earnings, media sentiment, analyst recommendations, profitability, institutional ownership and risk. Which has better earnings & valuation, QMMM or ISPC? QMMM has higher earnings, but lower revenue than iSpecimen. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQMMM$3.51M3.00N/AN/AN/AiSpecimen$10.39M0.28-$11.10M-$19.10-0.16 Does the MarketBeat Community believe in QMMM or ISPC? iSpecimen received 3 more outperform votes than QMMM when rated by MarketBeat users. CompanyUnderperformOutperformQMMMN/AN/AiSpecimenOutperform Votes375.00% Underperform Votes125.00% Do insiders and institutionals have more ownership in QMMM or ISPC? 13.6% of iSpecimen shares are owned by institutional investors. 12.2% of iSpecimen shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Is QMMM or ISPC more profitable? QMMM has a net margin of 0.00% compared to iSpecimen's net margin of -91.66%. QMMM's return on equity of 0.00% beat iSpecimen's return on equity.Company Net Margins Return on Equity Return on Assets QMMMN/A N/A N/A iSpecimen -91.66%-139.25%-73.97% Does the media favor QMMM or ISPC? In the previous week, iSpecimen had 1 more articles in the media than QMMM. MarketBeat recorded 1 mentions for iSpecimen and 0 mentions for QMMM. QMMM's average media sentiment score of 0.00 beat iSpecimen's score of -0.19 indicating that QMMM is being referred to more favorably in the media. Company Overall Sentiment QMMM Neutral iSpecimen Neutral SummaryQMMM and iSpecimen tied by winning 5 of the 10 factors compared between the two stocks. Ad True Market InsidersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team of crypto experts has identified it as the most promising crypto of 2024. You can see all of the details surrounding the #1 Crypto of 2024>3-Cent Amazon Coin< Get iSpecimen News Delivered to You Automatically Sign up to receive the latest news and ratings for ISPC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ISPC vs. The Competition Export to ExcelMetriciSpecimenCommercial physical research IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.89M$4.20B$5.14B$9.08BDividend YieldN/A1.78%5.09%4.23%P/E Ratio-0.1655.3490.0517.18Price / Sales0.2847.521,117.14116.99Price / CashN/A23.6243.0437.86Price / Book0.143.144.784.78Net Income-$11.10M$139.50M$120.31M$225.60M7 Day Performance2.74%-0.35%-1.92%-1.23%1 Month Performance-33.77%3.18%11.51%3.36%1 Year Performance502.89%14.18%30.61%16.60% iSpecimen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ISPCiSpecimen0.8826 of 5 stars$3.00+1.4%N/A+500.0%$2.89M$10.39M-0.1660News CoverageGap UpHigh Trading VolumeQMMMQMMMN/A$0.74+4.6%N/AN/A$12.78MN/A0.00N/AGap DownINTJIntelligent GroupN/A$0.91-6.2%N/AN/A$11.88M$22.76M0.0017News CoverageGap UpLIFWMSP Recovery0.9568 of 5 stars$1.78-1.7%N/A-94.4%$11.68M$10.73M-0.0188RVYLRyvyl0.3208 of 5 stars$1.52+8.6%N/A-74.9%$11.24M$63.53M-0.1850ESGLESGLN/A$1.22-3.1%N/A+100.7%$9.79M$6.26M0.00N/APositive NewsGap DownDRCTDirect Digital3.0371 of 5 stars$0.66-0.6%$21.00+3,077.0%-95.2%$9.69M$94.22M-0.5960APDNApplied DNA Sciences2.6346 of 5 stars$0.18+12.3%$1.50+711.7%-98.5%$9.47M$3.40M-0.0170Earnings ReportGap UpHigh Trading VolumeSRAXSRAXN/A$0.30+42.9%N/A+600.0%$8.75M$27.86M0.00130CAUDCollective AudienceN/A$0.35-18.1%N/A-68.6%$8.32M$12.14M0.0023Gap DownATIFATIF0.6129 of 5 stars$0.69-13.7%N/A-29.0%$8.23M$620,000.00-2.3310Gap DownHigh Trading Volume Related Companies and Tools Related Companies QMMM Competitors INTJ Competitors LIFW Competitors RVYL Competitors ESGL Competitors DRCT Competitors APDN Competitors SRAX Competitors CAUD Competitors ATIF Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ISPC) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iSpecimen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iSpecimen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ISPC Stock Alerts